Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malaria - Drugs In Development, 2022, provides an overview of the Malaria (Infectious Disease) pipeline landscape.

Malaria is a life-threatening blood disease caused by a parasite (Plasmodium) that is transmitted to humans by the Anopheles mosquito. People at increased risk of serious disease include young children and infants, travelers coming from areas with no malaria and pregnant women and their unborn children. Symptoms may include fever, chills, headache, sweats, fatigue, enlarged spleen, nausea and vomiting. Treatment includes anti-malarial medicines and healthy lifestyle.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Malaria - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Malaria (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule ty...

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malaria - Drugs In Development, 2021, provides an overview of the Malaria (Infectious Disease) pipeline landscape.Malaria is a life-threatening blood disease caused by a parasite (Plasmodium) that is transmitted to humans by the Anopheles mosquito. People at increased risk of serious disease include young children and infants, travelers coming from areas with no malaria and pregnant women and their unborn children. Symptoms may include fever, chills, headache, sweats, fatigue, enlarged spleen, nausea and vomiting. Treatment includes anti-malarial medicines and healthy lifestyle.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Malaria - Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Malaria (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The g...

Summary

Malaria is a vector-borne disease caused by parasites of the genus Plasmodium. Malaria is transmitted through the bite of the female Anopheles mosquito. Upon infecting a new human host, parasites first travel to liver cells and eventually infect erythrocytes (red blood cells). Once erythrocytes have been infected, patients may exhibit symptoms such as fever, headache, and chills. However, some patients exhibit no symptoms. If left untreated, malaria can progress to a severe form that results in cerebral malaria, anemia, respiratory distress, kidney failure, and possibly death.

GlobalData epidemiologists provide a 10-year epidemiological forecast for confirmed incident cases and confirmed deaths from malaria segmented by sex and age in these markets. This report also forecasts confirmed cases segmented by Plasmodium species, P. falciparum cases with K13 propeller mutations, and seroprevalence of Plasmodium infection in pregnant women.

In 2017, there were 33,158,385 confirmed incident cases of malaria in the 6MM. The DRC had the most cases with 15...

Summary

GlobalData's clinical trial report, “Malaria Global Clinical Trials Review, H2, 2017" provides an overview of Malaria clinical trials scenario. This report provides top line data relating to the clinical trials on Malaria. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note...

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Cerebral (Fatal) Malaria Overview 6
Therapeutics Development 7
Pipeline Products for Cerebral (Fatal) Malaria - Overview 7
Pipeline Products for Cerebral (Fatal) Malaria - Comparative Analysis 8
Cerebral (Fatal) Malaria - Therapeutics under Development by Companies 9
Cerebral (Fatal) Malaria - Therapeutics under Investigation by Universities/Institutes 10
Cerebral (Fatal) Malaria - Pipeline Products Glance 11
Clinical Stage Products 11
Early Stage Products 12
Cerebral (Fatal) Malaria - Products under Development by Companies 13
Cerebral (Fatal) Malaria - Products under Investigation by Universities/Institutes 14
Cerebral (Fatal) Malaria - Companies Involved in Therapeutics Development 15
Callaghan Innovation Research Ltd 15
Eisai Co Ltd 16
Lipocure Ltd 17
Cerebral (Fatal) Malaria - Therapeutics Assessment 18
Assessment by Monotherapy Products 18
Assessment by Target 19
Assessme...